ORKA Stock Falls 5% Despite Positive Week 28 Psoriasis Efficacy Data
ORKA shares fell roughly 5% the day of its Week 28 plaque psoriasis efficacy readout, per TradingView, a reminder that biotech markets and dermatology clinicians often parse the same data on differen…